English Abstract
Journal Article
Research Support, Non-U.S. Gov't
Add like
Add dislike
Add to saved papers

[The application of combined detection of autoantibodies in primary Sjögren's syndrome].

OBJECTIVE: To compare the specificity and sensitivity of antibodies against SSA and SSB, anti-M3 receptor polypeptide antibodies, anti-alpha-fodrin (IgG) antibodies in primary Sjögren's syndrome (pSS).

METHODS: One hundred and ten pSS patients (mean age was 49.2 +/- 14. 8, mean disease duration was 5.6 +/- 4.6), 80 systemic lupus erythematosus (SLE) patients (mean age was 25.5 +/- 4.6, mean disease duration was 2.5 +/- 1.2) and 80 rheumatoid arthritis (RA) patients (mean age was 44.6 +/- 3.5, mean disease duration was 4.2 +/- 1.1) were studied. Enzyme-linked immunosorbent assay was used to measure these antibodies.

RESULTS: The seropositive rates of anti-SSA, anti-SSB antibodies, anti-M3 receptor polypeptide antibodies and anti-alpha-fodrin (IgG) antibodies were 45.5%, 30.9%,78.2% and 77.3%, respectively in pSS. They were much higher than those in RA and SLE patients (P < 0.05). Specificities of SSA, SSB antibodies, anti-M3 receptor antibodies and anti-alpha-fodrin IgG were 83.8%, 97.7%, 92.0% and 90.0% respectively. With the combination of these antibodies in the diagnosis of pSS, the sensitivity can be increased at least to 88.2% and the specificity was not decreased significantly.

CONCLUSION: Combination of these antibodies can significantly improve the sensitivity of these antibodies in the diagnosis of pSS. Anti-SSA and SSB antibodies, anti-M3 receptor antibodies and anti-alpha-fodrin (IgG) antibodies are specific antibodies for the diagnosis of pSS.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app